CEBPB and neoplasm: Siow et al. [31] indicated that its overexpression would be related to the tumor stage, with a special relevance in the early stages, while others described [32] that the activation of the EGFR-AKT-CEBPb pathway would promote overexpression of miR-31 in oral cancer.